Acute myeloid leukemia (AML) -- Treatment of adult acute lymphoblastic leukemia (ALL): risk stratification and strategies -- Chronic lymphocytic leukemia (CLL) -- Myelodysplastic syndromes (MDS) -- Myeloablative transplant (HCT) -- Reduced-intensity and non-myeloablative conditioning followed by hematopoietic cell transplantation -- Alternative donor hematopoietic stem cell transplantation: a role for umbilical cord blood transplantation for hematologic malignancies -- Detection and significance of minimal residual disease -- Late effects after treatment for leukemia -- Transfusion support of the patient with hematologic malignancy -- Infections in leukemia and hematopoietic stem cell transplantation